Literature DB >> 12411762

Comparative diagnostic utility of different MR modalities in mild cognitive impairment and Alzheimer's disease.

Kejal Kantarci1, YueCheng Xu, Maria M Shiung, Peter C O'Brien, Ruth H Cha, Glenn E Smith, Robert J Ivnik, Bradley F Boeve, Steven D Edland, Emre Kokmen, Eric G Tangalos, Ronald C Petersen, Clifford R Jack.   

Abstract

This study compares the diagnostic accuracy of magnetic resonance (MR)-based hippocampal volumetry, single voxel (1)H MR spectroscopy ((1)H MRS) and MR diffusion-weighted imaging (DWI) measurements in discriminating patients with amnestic mild cognitive impairment (MCI), Alzheimer's disease (AD) and normally aging elderly. Sixty-one normally aging elderly, 24 MCI and 22 AD patients underwent MR-based hippocampal volumetry, (1)H MRS and DWI. (1)H MRS voxels were placed over both of the posterior cingulate gyri, and N-acetyl aspartate (NAA)/creatine (Cr), myoinositol (MI)/Cr and NAA/MI ratios were obtained. Apparent diffusion coefficient (ADC) maps were derived from DWI, and hippocampal borders were traced to measure hippocampal ADC. At 80% specificity, the most sensitive single measurement to discriminate MCI (79%) and AD (86%) from controls was hippocampal volumes. The most sensitive single measurement to discriminate AD from MCI was posterior cingulate gyrus NAA/Cr (67%). At high specificity (>85-90%), combinations of MR measures had superior diagnostic sensitivity compared with any single MR measurement for the AD vs. control and control vs. MCI comparisons. The MR measures that best discriminate more from less affected individuals along the cognitive continuum from normal to AD vary with disease severity. Selection of imaging measures used for clinical assessment or monitoring efficiency of therapeutic intervention should be tailored to the clinical stage of the disease. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2002        PMID: 12411762      PMCID: PMC2796574          DOI: 10.1159/000066021

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  39 in total

Review 1.  Diffusion-weighted MR imaging in acute stroke: theoretic considerations and clinical applications.

Authors:  J M Provenzale; A G Sorensen
Journal:  AJR Am J Roentgenol       Date:  1999-12       Impact factor: 3.959

2.  Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment.

Authors:  J H Kordower; Y Chu; G T Stebbins; S T DeKosky; E J Cochran; D Bennett; E J Mufson
Journal:  Ann Neurol       Date:  2001-02       Impact factor: 10.422

3.  "Preclinical" AD revisited: neuropathology of cognitively normal older adults.

Authors:  F A Schmitt; D G Davis; D R Wekstein; C D Smith; J W Ashford; W R Markesbery
Journal:  Neurology       Date:  2000-08-08       Impact factor: 9.910

4.  CSF-suppressed quantitative single-shot diffusion imaging.

Authors:  K K Kwong; R C McKinstry; D Chien; A P Crawley; J D Pearlman; B R Rosen
Journal:  Magn Reson Med       Date:  1991-09       Impact factor: 4.668

5.  Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD.

Authors:  Y Xu; C R Jack; P C O'Brien; E Kokmen; G E Smith; R J Ivnik; B F Boeve; R G Tangalos; R C Petersen
Journal:  Neurology       Date:  2000-05-09       Impact factor: 9.910

6.  Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study.

Authors:  K Kantarci; C R Jack; Y C Xu; N G Campeau; P C O'Brien; G E Smith; R J Ivnik; B F Boeve; E Kokmen; E G Tangalos; R C Petersen
Journal:  Neurology       Date:  2000-07-25       Impact factor: 9.910

Review 7.  Magnetic resonance spectroscopy in AD.

Authors:  M J Valenzuela; P Sachdev
Journal:  Neurology       Date:  2001-03-13       Impact factor: 9.910

8.  Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse.

Authors:  D Schenk; R Barbour; W Dunn; G Gordon; H Grajeda; T Guido; K Hu; J Huang; K Johnson-Wood; K Khan; D Kholodenko; M Lee; Z Liao; I Lieberburg; R Motter; L Mutter; F Soriano; G Shopp; N Vasquez; C Vandevert; S Walker; M Wogulis; T Yednock; D Games; P Seubert
Journal:  Nature       Date:  1999-07-08       Impact factor: 49.962

9.  Memory and mental status correlates of modified Braak staging.

Authors:  E Grober; D Dickson; M J Sliwinski; H Buschke; M Katz; H Crystal; R B Lipton
Journal:  Neurobiol Aging       Date:  1999 Nov-Dec       Impact factor: 4.673

10.  Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease.

Authors:  R J Killiany; T Gomez-Isla; M Moss; R Kikinis; T Sandor; F Jolesz; R Tanzi; K Jones; B T Hyman; M S Albert
Journal:  Ann Neurol       Date:  2000-04       Impact factor: 10.422

View more
  33 in total

1.  [MR spectroscopy in dementia].

Authors:  T Hauser; L Gerigk; F Giesel; L Schuster; M Essig
Journal:  Radiologe       Date:  2010-09       Impact factor: 0.635

2.  Quantitative MR analyses of the hippocampus: unspecific metabolic changes in aging.

Authors:  András Szentkuti; Sebastian Guderian; Kolja Schiltz; Jörn Kaufmann; Thomas F Münte; Hans-Jochen Heinze; Emrah Düzel
Journal:  J Neurol       Date:  2004-11       Impact factor: 4.849

Review 3.  Efficacy of proton magnetic resonance spectroscopy in neurological diagnosis and neurotherapeutic decision making.

Authors:  Alexander Lin; Brian D Ross; Kent Harris; Willis Wong
Journal:  NeuroRx       Date:  2005-04

Review 4.  N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology.

Authors:  John R Moffett; Brian Ross; Peethambaran Arun; Chikkathur N Madhavarao; Aryan M A Namboodiri
Journal:  Prog Neurobiol       Date:  2007-01-05       Impact factor: 11.685

5.  Diffusion tensor imaging of the hippocampus and verbal memory performance: the RUN DMC study.

Authors:  Anouk G W van Norden; Karlijn F de Laat; Ilma Fick; Inge W M van Uden; Lucas J B van Oudheusden; Rob A R Gons; David G Norris; Marcel P Zwiers; Roy P C Kessels; Frank-Erik de Leeuw
Journal:  Hum Brain Mapp       Date:  2011-03-09       Impact factor: 5.038

6.  Role of very high order and degree B0 shimming for spectroscopic imaging of the human brain at 7 tesla.

Authors:  Jullie W Pan; Kai-Ming Lo; Hoby P Hetherington
Journal:  Magn Reson Med       Date:  2011-12-28       Impact factor: 4.668

7.  Tensor-based morphometry with stationary velocity field diffeomorphic registration: application to ADNI.

Authors:  Matias Bossa; Ernesto Zacur; Salvador Olmos
Journal:  Neuroimage       Date:  2010-03-06       Impact factor: 6.556

8.  The anteroposterior and primary-to-posterior limbic ratios as MRI-derived volumetric markers of Alzheimer's disease.

Authors:  Adolfo Jiménez-Huete; Susana Estévez-Santé
Journal:  J Neurol Sci       Date:  2017-04-27       Impact factor: 3.181

9.  Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI).

Authors:  Susanne G Mueller; Michael W Weiner; Leon J Thal; Ronald C Petersen; Clifford R Jack; William Jagust; John Q Trojanowski; Arthur W Toga; Laurel Beckett
Journal:  Alzheimers Dement       Date:  2005-07       Impact factor: 21.566

10.  Alzheimer disease: postmortem neuropathologic correlates of antemortem 1H MR spectroscopy metabolite measurements.

Authors:  Kejal Kantarci; David S Knopman; Dennis W Dickson; Joseph E Parisi; Jennifer L Whitwell; Stephen D Weigand; Keith A Josephs; Bradley F Boeve; Ronald C Petersen; Clifford R Jack
Journal:  Radiology       Date:  2008-07       Impact factor: 11.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.